Email: cspc@cspc.cn
News
News Center
Dec. 09
2024
ACCEPTANCE OF APPLICATION FOR MARKETING APPROVAL OF SYHX2011 FOR THE TREATMENT OF ADVANCED BREAST CANCER
Dec. 04
CRB-701 (SYS6002) GRANTED FAST TRACK DESIGNATION BY THE U.S. FDA
TEDIZOLID PHOSPHATE TABLETS OBTAINS DRUG REGISTRATION APPROVAL
Nov. 27
ACCEPTANCE OF BIOLOGIC LICENSE APPLICATION OF USTEKINUMAB INJECTION
Nov. 12
BIVALENT HPV mRNA THERAPEUTIC VACCINE (SYS6026)OBTAINS CLINICAL TRIAL APPROVAL
Oct. 25
VOLUNTARY ANNOUNCEMENT FIRST mRNA-LNP-BASED CAR-T CELL INJECTION (SYS6020) OBTAINS FURTHER CLINICAL TRIAL APPROVAL FOR NEW INDICATION
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
